BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9453320)

  • 1. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
    Li PL; Jin MW; Campbell WB
    Hypertension; 1998 Jan; 31(1 Pt 2):303-8. PubMed ID: 9453320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.
    Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM
    J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
    Olson LJ; Knych ET; Herzig TC; Drewett JG
    Hypertension; 1997 Jan; 29(1 Pt 2):254-61. PubMed ID: 9039111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
    Onoue H; Katusic ZS
    Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cGMP mediated relaxation in small rat coronary arteries by block of CA++ activated K+ channels.
    Price JM; Hellermann A
    Life Sci; 1997; 61(12):1185-92. PubMed ID: 9315509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
    Hanke CJ; Drewett JG; Myers CR; Campbell WB
    Endocrinology; 1998 Oct; 139(10):4053-60. PubMed ID: 9751482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the iberiotoxin-sensitive BKCa channels by salvianolic acid B of the porcine coronary artery smooth muscle cells.
    Lam FF; Seto SW; Kwan YW; Yeung JH; Chan P
    Eur J Pharmacol; 2006 Sep; 546(1-3):28-35. PubMed ID: 16928370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation to authentic nitric oxide and SIN-1 in rat isolated mesenteric arteries: variable role for smooth muscle hyperpolarization.
    Plane F; Sampson LJ; Smith JJ; Garland CJ
    Br J Pharmacol; 2001 Jul; 133(5):665-72. PubMed ID: 11429390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    Brunner F; Schmidt K; Nielsen EB; Mayer B
    J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
    Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of cyclic GMP and potassium channels in relaxation evoked by the nitric oxide donor, diethylamine NONOate, in the rat small isolated mesenteric artery.
    Sampson LJ; Plane F; Garland CJ
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):220-5. PubMed ID: 11521164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of nitric oxide-induced relaxation of porcine coronary artery: roles of the dimers of soluble guanylyl cyclase, phosphodiesterase type 5, and cGMP-dependent protein kinase.
    Liu J; Chen Z; Ye L; Liu H; Dou D; Liu L; Yu X; Gao Y
    Pflugers Arch; 2014 Oct; 466(10):1999-2008. PubMed ID: 24413911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium- and smooth muscle-dependent vasodilator effects of Citrus aurantium L. var. amara: Focus on Ca(2+) modulation.
    Kang P; Ryu KH; Lee JM; Kim HK; Seol GH
    Biomed Pharmacother; 2016 Aug; 82():467-71. PubMed ID: 27470386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries.
    Sun CW; Falck JR; Okamoto H; Harder DR; Roman RJ
    Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H339-50. PubMed ID: 10899074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iloprost dilates rat small arteries: role of K(ATP)- and K(Ca)-channel activation by cAMP-dependent protein kinase.
    Schubert R; Serebryakov VN; Mewes H; Hopp HH
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1147-56. PubMed ID: 9087587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of guanylyl cyclase and protein kinase G inhibitors on vasodilatation in non-tolerant and tolerant bovine coronary arteries.
    De la Lande IS; Stafford I; Horowitz JD
    Eur J Pharmacol; 1999 Apr; 370(1):39-46. PubMed ID: 10323278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery.
    Qin X; Zheng X; Qi H; Dou D; Raj JU; Gao Y
    Pflugers Arch; 2007 Sep; 454(6):913-23. PubMed ID: 17377806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of guanylyl cyclase, protein kinase A and Na+ K+ ATPase in relaxations of bovine isolated bronchioles induced by GEA 3175, an NO donor.
    Elmedal Laursen B; Mulvany MJ; Simonsen U
    Pulm Pharmacol Ther; 2006; 19(3):179-88. PubMed ID: 16023394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.